Your browser doesn't support javascript.
loading
Overcoming resistance to rituximab in relapsed non-Hodgkin lymphomas by antibody-polymer drug conjugates actively targeted by anti-CD38 daratumumab.
Lidický, Ondrej; Klener, Pavel; Machová, Daniela; Vocková, Petra; Pokorná, Eva; Helman, Karel; Mavis, Cory; Janousková, Olga; Etrych, Tomás.
Afiliação
  • Lidický O; Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovský Sq. 2, 162 06 Prague 6, Czech Republic.
  • Klener P; Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovský Sq. 2, 162 06 Prague 6, Czech Republic; Institute of Pathological Physiology, First Faculty of Medicine, Charles University, U Nemocnice 5, 128 53 Prague 2, Czech Republic; First Department of Internal Medici
  • Machová D; Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovský Sq. 2, 162 06 Prague 6, Czech Republic.
  • Vocková P; Institute of Pathological Physiology, First Faculty of Medicine, Charles University, U Nemocnice 5, 128 53 Prague 2, Czech Republic; First Department of Internal Medicine- Hematology, University General Hospital and First Faculty of Medicine, Charles University, U Nemocnice 2, 128 08 Prague 2, Czech
  • Pokorná E; Institute of Pathological Physiology, First Faculty of Medicine, Charles University, U Nemocnice 5, 128 53 Prague 2, Czech Republic.
  • Helman K; Faculty of Informatics and Statistics, University of Economics, Prague, Czech Republic.
  • Mavis C; Department of Medicine Lymphoma/Myeloma, Roswell Park, Comprehensive Cancer Center, Elm & Carlton Sts, Buffalo, NY 14263, United States of America.
  • Janousková O; Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovský Sq. 2, 162 06 Prague 6, Czech Republic.
  • Etrych T; Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovský Sq. 2, 162 06 Prague 6, Czech Republic. Electronic address: etrych@imc.cas.cz.
J Control Release ; 328: 160-170, 2020 12 10.
Article em En | MEDLINE | ID: mdl-32860930

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Preparações Farmacêuticas / Antineoplásicos Limite: Humans Idioma: En Revista: J Control Release Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Preparações Farmacêuticas / Antineoplásicos Limite: Humans Idioma: En Revista: J Control Release Ano de publicação: 2020 Tipo de documento: Article